Tiverton Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-29,216
Closed -$364K 536
2018
Q1
$364K Sell
29,216
-87,450
-75% -$1.06M 0.03% 250
2017
Q4
$1.63M Sell
116,666
-58,334
-33% -$855K 0.1% 157
2017
Q3
$2.94M Sell
175,000
-21,950
-11% -$357K 0.17% 131
2017
Q2
$3.31M Sell
196,950
-65,550
-25% -$980K 0.18% 133
2017
Q1
$4.07M Hold
262,500
0.21% 132
2016
Q4
$3.92M Hold
262,500
0.23% 118
2016
Q3
$3.3M Buy
+262,500
New +$2.63M 0.26% 107
2016
Q2
Sell
-504,000
Closed -$5M 158
2016
Q1
$5M Sell
504,000
-111,531
-18% -$1.14M 0.17% 109
2015
Q4
$7.08M Sell
615,531
-109,469
-15% -$1.35M 0.22% 100
2015
Q3
$9.79M Hold
725,000
0.22% 101
2015
Q2
$10M Hold
725,000
0.2% 113
2015
Q1
$10.2M Buy
725,000
+212,900
+42% +$2.9M 0.21% 102
2014
Q4
$6.97M Hold
512,100
0.15% 110
2014
Q3
$7.82M Buy
512,100
+397,645
+347% +$6.09M 0.18% 105
2014
Q2
$1.93M Buy
+114,455
New +$2.06M 0.04% 119

Other funds holding OXFD

Tiverton Asset Management's OXFD Position: Q2 2018 in Review

Tiverton Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2018, closing a stake of 29,216 shares — an estimated $364K sold.

Tiverton Asset Management first reported a position in OXFD in Q2 2014 and held it in 15 quarters. The position peaked at $10.2M in Q1 2015. 77 funds tracked by Wall St. Rank hold OXFD as of Q2 2018.

  • Tiverton Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 29,216 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2018, an estimated $364K.
  • Tiverton Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2014 and held it in 15 quarters.
  • Tiverton Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $10.2M in Q1 2015.
  • 77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2018.

Based on Tiverton Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.